No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage

British Journal of Haematology

Volumn 144, Issue 5, 2009, Pages 802-803

  Dahabreh, Issa J ^a,b   Jones, Amy V ^c   Voulgarelis, Michael ^b   Giannouli, Stavroula ^b   Zoi, Christine ^a,b   Alafakis Tzannatos, Christina ^d   Varla Leftherioti, Marighoula ^e   Moutsopoulos, Haralampos M ^b   Loukopoulos, Dimitris ^a   Fotiou, Stelios ^b   Cross, Nicholas C P ^c   Zoi, Katerina ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d IASO   (Greece)

^e HELENA VENIZELOU HOSPITAL   (Greece)

Author keywords

Essential thrombocythaemia; JAK2 V617F; Myeloproliferative neoplasms; Polycythaemia vera; Pregnancy complications; Recurrent miscarriage

Indexed keywords

JANUS KINASE 2;

DISEASE ASSOCIATION; GENE MUTATION; HUMAN; LETTER; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; GENE EXPRESSION; HUMANS; JANUS KINASE 2; MIDDLE AGED; MUTATION; PREGNANCY; YOUNG ADULT;

EID: 58849154581     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07510.x     Document Type: Letter

References (6)

1. Elliott, MA Tefferi, A (2003) Thrombocythaemia and pregnancy. Best Practice Research Clinical Haematology, 16, 227 242.
2. Griesshammer, M, Bergmann, L Pearson, T (1998) Fertility, pregnancy and the management of myeloproliferative disorders. Baillieres Clinical Haematology, 11, 859 874.
3. Jones, AV, Kreil, S, Zoi, K, Waghorn, K, Curtis, C, Zhang, L, Score, J, Seear, R, Chase, AJ, Grand, FH, White, H, Zoi, C, Loukopoulos, D, Terpos, E, Vervessou, EC, Schultheis, B, Emig, M, Ernst, T, Lengfelder, E, Hehlmann, R, Hochhaus, A, Oscier, D, Silver, RT, Reiter, A Cross, NC (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 106, 2162 2168.
4. Mercier, E, Lissalde-Lavigne, G Gris, JC (2007) JAK2 V617F mutation in unexplained loss of first pregnancy. New England Journal of Medicine, 357, 1984 1985.
5. Passamonti, F, Randi, ML, Rumi, E, Pungolino, E, Elena, C, Pietra, D, Scapin, M, Arcaini, L, Tezza, F, Moratti, R, Pascutto, C, Fabris, F, Morra, E, Cazzola, M Lazzarino, M (2007) Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK (617V>F) mutation. Blood, 110, 485 489.
6. Robinson, S, Bewley, S, Hunt, BJ, Radia, DH Harrison, CN (2005) The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica, 90, 1477 1483.